Lemonex
Latest round
- Series C
Last raised
- Apr 2021
Total raised
- $27M
Investors
- 16
About Lemonex
Based in Seoul, South Korea, and founded in 2013, Lemonex Inc. is a biotherapeutics biotechnology company that uses drug delivery and biosensor technologies to develop cancer immunotherapeutic, antibody therapeutics, and gene therapeutics. In 2019, the company received innovation award for small and middle size businesses. In 2020, the company received certificate of excellent technology evaluation. The company's current CEO is Cheolhee Won. The company uses its unique drug delivery and biosensor technologies to develop new drugs. Its drug delivery technology known as DegradaBALL is used in gene therapy, cancer immuno therapy, antibody therapy, and synthetic drugs. The company's biosensor technology known as PANGO is a molecular diagnostic and drug screening technology that are used in developing new virus therapeutics and anti-cancer vaccines. The company's pipeline for cancer immunotherapy & targeted cancer therapy includes BALLkine-2, LEM-S403, LEM-S404, and LEM-S405. Pipelines for intractable disease include LEM-S401 and LEM-S402.
Who invested in Lemonex
16 investors across 4 rounds
See all investors in Lemonex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lemonex
Who invested in Lemonex?
Lemonex has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lemonex raised?
Lemonex has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Lemonex last raise money?
Lemonex's most recent round on record is a Series C, in Apr 2021.
What does Lemonex do?
Based in Seoul, South Korea, and founded in 2013, Lemonex Inc.
Where is Lemonex headquartered?
Lemonex is headquartered in Seoul, South Korea.
Which VCs invest in companies like Lemonex?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Lemonex's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Lemonex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.